Tendinitis

Tendinitis – ROJoson Random Notes – May 29, 2019
Tendinitis, also called overuse tendinopathy, typically is diagnosed by a physical exam alone.

The goals of treatment for overuse tendinopathy are to restore movement to the joint without pain and to maintain strength in surrounding muscles while giving the tissues time to heal.

As an immediate treatment for overuse tendinopathy, doctors and physical therapists often recommend the RICE program: rest, ice, compression, and elevation of the injured tendon.

The goals of tendinitis treatment are to relieve your pain and reduce inflammation. Often, taking care of tendinitis on your own — including rest, ice and over-the-counter pain relievers — may be all the treatment that you need.

An exercise plan that rests the tendon while strengthening nearby muscle groups and maintaining overall muscle tone is recommended.

Although rest is a key part of treating tendinitis, prolonged inactivity can cause stiffness in your joints. After a few days of completely resting the injured area, gently move it through its full range of motion to maintain joint flexibility.

Prevention – Try to prevent repetitive use of the same joint, resting it when possible.

Don’t be too quick to jump into steroid injection and surgery. Try above mentioned non-invasive procedures first, particularly, exercises.

Personally, I had bouts of tendinitis before (about 2x). Last one was in January 2019, tendinitis of the left index finger. I just use alternating rest and exercise (more on exercise). I did not have to take pain-killers. I did not consider steroid injection. The tendinitis resolved eventually about 2 months. I need to continue my exercises on my fingers and to try to avoid excessive and strenuous use of my fingers. I have to reduce my windsurfing activity as it puts strain on my fingers.

The first bout was in 2016. I retrieved my personal records.
Thumb Tendinitis, left ( De Quervain’s Tendinosis) – 16feb3 – conservative treatment – analgesics – slight exercise – relieved after 3 days – still with residual mild discomfort – as of 16feb24 – 3 weeks after. Resolved in March 2016. No recurrence thereafter – as of June 4, 2018 (AND UP TO NOW – 2019 – 3 YEARS AFTER).

PERSONAL ADVICE: DON’T BE TOO QUICK TO JUMP INTO STEROID INJECTION AND SURGERY.


ROJ@19may29

Posted in Tendinitis | Leave a comment

Fatty Liver

Problem-based Learning on FATTY LIVER

What is fatty liver?

Fatty liver, or hepatic steatosis, is a term that describes the buildup of fat in the liver. It’s normal to have small amounts of fat in your liver, but too much can become a health problem.

What are the common types of fatty liver?

There are two basic types of fatty liver: nonalcoholic and alcoholic.

What are the usual or common causes of fatty liver?

Alcoholic fatty liver – alcohol

Non-alcoholic fatty liver are linked to the following:

  • Overweight or obesity
  • Insulin resistance, in which your cells don’t take up sugar in response to the hormone insulin
  • High blood sugar (hyperglycemia), indicating prediabetes or actual type 2 diabetes
  • High levels of fats, particularly triglycerides, in the blood

How is fatty liver usually diagnosed?

Ultrasound (usually)

Computerized tomography (CT) scanning or magnetic resonance imaging (MRI) of the abdomen – as needed

Blood tests

Primary:

  • Liver enzyme and liver function tests
  • Lipid profile, which measures blood fats, such as cholesterol and triglycerides

Secondary:

  • Tests for chronic viral hepatitis (hepatitis A, hepatitis C and others)
  • Fasting blood sugar
  • Hemoglobin A1C, which shows how stable your blood sugar is

How is fatty liver treated?

No FDA-approved medications for fatty liver disease.

The most effective treatment: lifestyle changes

The good news is that the most effective treatment so far for fatty liver disease does not involve medications, but rather lifestyle changes.

Lose weight.

Exercise.

Eat well.

Keeping your liver healthy

If you have been diagnosed with fatty liver disease, it is important to keep your liver as healthy as possible and avoid anything that can damage your liver. Here are some important things you should do.

  • Don’t drink too much alcohol. How much is too much remains controversial, but it’s probably best to avoid alcohol completely.
  • Make sure that none of your medications, herbs, and supplements are toxic to the liver; you can crosscheck your list with this LiverTox database. Even acetaminophen (the generic ingredient in Tylenol and some cold medicines) may be harmful if you take too much for too long, especially if you have liver disease or drink alcohol heavily.
  • Get vaccinated to protect against liver viruses hepatitis A and B.
  • Control other health conditions that might also affect your liver, and check with your doctor if you might have other underlying, treatable diseases contributing to your fatty liver.
  • Get regular screening tests for liver cancer if you already have cirrhosis.

What is the prognosis of fatty liver?

Good as long as properly controlled and properly treatment (see above – how is fatty liver treated).

 

References:

https://www.health.harvard.edu/blog/fatty-liver-disease-what-it-is-and-what-to-do-about-it-2019011015746

https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567

https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/diagnosis-treatment/drc-20354573


ROJ@19may4

Posted in Liver | Leave a comment

Histopathology report – how long does it take – what is the ideal turn around time

How long does it take for a histopathology report to come in after the procedure, say a biopsy or an operation?

A histopathology is the examination of tissues obtained from the body under a microscope.  A histopathology report describes the tissue that has been sent for examination to the pathologists for examination.  It also contains a diagnosis.

What should be the ideal turn around time for the histopathology report?  This turn around time should be considered as it is sought after only by the patients, but also by the physicians and the hospital administration.  For the patients, they are anxious to know the report as soon as possible (waiting is an agony).  Also, if they are confined in the hospital, they want to know the report as soon as possible so as not to unnecessarily prolong their hospital stay.  For the physicians, particularly the surgeons, they are anxious to know the report as soon as possible (they want to know whether they make the right diagnosis and correspondingly, right decision; they want to tell their patients as soon as possible to avoid anxiety; they want to proceed to any further treatment that may be needed as soon as possible; etc.).  For the hospital administration, turn around time is an issue of quality, efficiency, and most important of all, patient experience.

In the Philippines, from personal experience, the turn around time (TAT) in hospital ranges from 3 days to 3 weeks.  Ideally, the TAT should be within one week, better, if 3 days.  TAT of two weeks is long.  More so, if 3 weeks.  Unnecessarily prolonged TAT is usually seen in government hospitals where there are a lot of administrative issues present such as caseload, lack of processing materials and equipment, lack of manpower, etc.

As mentioned, the shortest TAT is about 3 days.  This is the best scenario.  The TAT of 3 days may be prolonged to about a week or longer if additional testing such as special stains and immunohistochemistry are required.

Below is a nice link that gives us an idea of the processing of the tissues to get a histopathology result:

Why does it takes so long to get cancer results from pathology?

https://www.quora.com/Why-does-it-takes-so-long-to-get-cancer-results-from-pathology

main-thumb-28015224-50-nqxgikxorzcovryojttsgrztqldjzgyn
Jung Hoon Son, M.D., Biomedical Informaticist and Board Certified Anatomical and Clinical Pathologist

I’ll break it down by days:

  • Day 0: Biopsy/Surgery
  • Day 0-1:Received by lab. Sometimes for late procedures, the specimen gets to pathology labs late, and the specimen will be processed for the next day cycle. Specimen will be sent to be adequately fixed in formalin for optimal preservation/stains.

main-qimg-1afc2b21045a254152d09a3e5f1aa9b9-c

  • Day 0-2: Specimen is embedded into paraffin blocks:

main-qimg-f68a89b01bea9b98ae72e2ca92ba4555-c

  • To be cut into thin sections on to a glass slide.

main-qimg-a972bb7fbe1e7ac778286e7511ec18f5-c

main-qimg-550d496969aa54ea51091a62c0370850-c

The most basic stain for pathology lab is Hematoxylin and Eosin stain (H&E).

main-qimg-b8f29576210fe3758bae1c0c2479b8a8-c

  • Day 1-3: The slide is ready for interpretation for the first time by an anatomical pathologist. Who determines whether to sign out the case purely on H&E diagnosis, or whether additional studies (immunohistochemical stains or special stains) or additional tissue needs to be examined.

main-qimg-7f325f4b9de91188efa7d08c89b50b24-c

  • Day 2-5: Additional studies usually come out 1-2 days after microscopic examination of H&E. The pathologists may need more than 1st set of additional studies, delaying the process.

This is ROUTINE workup for diagnosis. Complex cases may need consultations within the department. Specimen delivery and acquisition-related problems also occur, holding up cases.




ROJ@18dec25

Posted in Histopathology Report | Leave a comment

I am an Advocate of Problem-based Learning in Medicine and Surgery

PBL_MED_SURG_ROJ_12aug4

processes_pbli_rj_12may13


ROJ@18may25

Posted in Problem-based Learning in Medicine (Surgery) | Leave a comment

Frequency categories of events in medicine

Drug adverse events 

Frequency categories based on one year event rates:

Very common                                              >/= 1 in 10

Common                                                      >/= 1 in 100 and < 1 in 10

Uncommon                                                  >/= 1 in 1,000 and < 1 in 100

Rare                                                              >/= 1 in 10,000 and < 1 in 1,000

Very rare                                                      < 1/10,000

 



 

I have to look up the frequency categories for surgical complications as well as diseases.



Some notes:



 

https://en.wikipedia.org/wiki/Rare_disease

There is no single, widely accepted definition for rare diseases. Some definitions rely solely on the number of people living with a disease, and other definitions include other factors, such as the existence of adequate treatments or the severity of the disease.

In the United States, the Rare Diseases Act of 2002 defines rare disease strictly according to prevalence, specifically “any disease or condition that affects fewer than 200,000 people in the United States”,[3] or about 1 in 1,500 people. This definition is essentially like that of the Orphan Drug Act of 1983, a federal law that was written to encourage research into rare diseases and possible cures.

In Japan, the legal definition of a rare disease is one that affects fewer than 50,000 patients in Japan, or about 1 in 2,500 people.[4]

However, the European Commission on Public Health defines rare diseases as “life-threatening or chronically debilitating diseases which are of such low prevalence that special combined efforts are needed to address them.”[5] The term low prevalence is later defined as generally meaning fewer than 1 in 2,000 people.[6] Diseases that are statistically rare, but not also life-threatening, chronically debilitating, or inadequately treated, are excluded from their definition.

The definitions used in the medical literature and by national health plans are similarly divided, with definitions ranging from 1/1,000 to 1/200,000.[4]



Am J Med Genet A. 2009 Jul;149A(7):1460-2. doi: 10.1002/ajmg.a.32924.

Qualitative descriptors of disease incidence: commonly used and frequently muddled.

Abstract

Words such as “frequent,” “common,” “uncommon,” and “rare” are used qualitatively to discuss disease incidence. They give a subjective assessment of disease frequency and are, thus, open to interpretation.

 

https://www.ncbi.nlm.nih.gov/pubmed/19533779


ROJ@17oct21

Posted in Frequency Category | Leave a comment

Scars

Nobody leaves this world without a scar, without a scar on the skin.

 

Scar Formation

A skin scar forms after a wound on the skin is caused by trauma or created by the surgeon. Skin scar is a form of wound healing.

There are three outcomes of wound healing:

  • Normal scar formation – a scar that is flat and pale in color or almost blending with the surrounding skin.
  • Hypertrophic scar – a scar raised above the skin level that stays within the confines of the original wound.
  • Keloid – a scar raised above skin level that proliferates beyond the confines of the original wound.

What factors affect the outcome of wound healing, whether there will be a normal scar formation, hypertrophic scar, or keloid?

  • Genetic
  • Status of the wound at the time of wounding such as whether it was a dirty wound, linear, ruggedly lacerated, or big gaping wound, etc.
  • How the wound was treated by the physician or surgeon

The physician or surgeon can only do so much in promoting a normal scar formation such as:

  • Close wound by primary intention if possible
  • Close wound without tension
  • Close wound with proper apposition of skin edges
  • Use of proper sutures
  • etc.

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

To use or not to use topical scar reduction medication:

First of all, there are no hard evidence yet of whether they are effective.  All are anecdotal reports.

Use of topical medications to promote good scar formation:

In the market, Contractubex, Dermatix Ultra, Hiruscar, Hirudoid

Not well established as to effectiveness

High risk for keloids – past history of keloids, wound in areas where keloid is frequent, family history of keloids

Try topical medications

  • Hiruscar
  • Hirudoid
  • Contractubex
  • Dermatix Ultra

Try Silicone Gel Sheet

First sign of hypertrophic scar – try topical medications

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

2014063054408207

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

Hypertropic scars develop approximately 39% to 68% of patients after surgery and 33% to 91% of patients after burns.

  • Niessen FB, Spauwen PH, Schalkwijk J, Kon M: On the nature of hypertrophic scars and keloids: a review.  Plast Reconstr Surg 104: 1435 – 1458, 1999.
  • Ward RS: Pressure therapy for the control of hypertrophic scar formation after burn injury: A history and review.  J Burn Care Rehabil 12:257-262, 1991

xxxxxxxxxxxxxxxxxxxxxxx

Wound healing processes (with overlaps):

  • Inflammation phase
  • Granulation tissue formation phase
  • Matrix formation or remodelling phase

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

There are a variety of treatments that have been tried for hypertrophic scars and keloids.  No optimal treatment has been established yet.

  • Intralesional steroids
  • Cryosurgery
  • Radiotherapy
  • Pressure therapy
  • Silicone gel sheeting
  • Laser therapy
  • Excisional surgery
  • Topical silicone gel (Dermatix)
  • Silicone gel sheeting
  • Onion extract (Contractubex)

Contractubex

Dermatix (more expensive) – seems to be better than Contractubex

Comparison of efficacy of silicone gel, silicone get sheeting, and topical onion extract including heparin and allantoin for the treatment of postburn hypertrophic scars

Turkey

Huseyin Karagoz, Fuat Yuksel, Ersin Ulkur, Rahmi Evinc

Elsevier 2009

xxxxxxxxxxxxxxxxxxxx

RTEmagicC_abnormal-scar-prevention_01.png

xxxxxxxxxxxxxxxxxxx

Scars are accepted phenomenon.

Patients were told that little could be done about them and that they have to accept the appearance of their scars.

 

xxxxxxxxxxxxxxxxxxxxxxxxxxx

Surgical approaches for the prevention and treatment of hypertrophic scars and keloids should be based on five main principles.

  1. General prophylactic approaches to minimize the risk of postoperative excessive scarring:
    • Delayed epithelialization beyond 10–14 days is known to increase the incidence of hypertrophic scarring dramatically10 thus achievement of rapid epithelialization is mandatory for avoiding excessive scar formation.
    • Wounds subjected to tension due to motion, body location, or loss of tissue are at increased risk of scar hypertrophy and spreading, and patients should be informed of this important matter prior to any surgery11
    • Aesthetic wound closure is based on knowledge of healing mechanisms and skin anatomy, as well as an appreciation of suture material and closure technique. Choosing the proper materials and wound closure technique ensures optimal healing. Surgical wound closure directly opposes the tissue layers, which serves to minimize new tissue formation within the wound. Appropriate surgical wound closure eliminates dead space by approximating the subcutaneous tissues, minimizes scar formation by careful epidermal alignment, and avoids depressed scars by precise eversion of skin edges. If dead space is limited with opposed wound edges, then new tissue has limited room for growth. Correspondingly, traumatic handling of tissues combined with avoidance of tight closures and undue tension on wound margins by carefully undermining and loosening the surrounding tissue contribute to a better result. We do prefer subcutaneous sutures with, for example, PDS II (polydioxanone) monoflament synthetic absorbable sutures, which provide extended wound support (for up to 6 months) and may be combined with absorbable sutures or Steri-Strip™ (3M, St Paul, MN, USA) for optimal epidermal wound closure. The group of Ogawa and colleagues employs subcutaneous fascial tensile reduction sutures in their predisposed patient population, where the tension is placed on the layer of deep fascia and superficial fascia. The group prefers 2-0 PDS II or 3-0 PDS II sutures for subcutaneous/fascial sutures, and 4-0 or 5-0 PDS II for dermal sutures.12
  2. In the case of hypertrophic scarring, timing of surgical treatment is an important consideration in the treatment protocol of scar revision strategy. Hypertrophic scars may mature over at least a 1-year period and can show significant flattening and softening without any physical manipulation.13Surgical excision might thus not be needed, even though post-excisional recurrence rates of the original hypertrophic scar are usually low.14,15 However, if scar (joint) contractures are present, surgical approaches that release contractures should be performed earlier.12
  3. Increased tension on wound margins represents a central aspect in the development of hypertrophic scars. Thus, successful and persisting removal of excessive scar tissue may be achieved by employing Z- or W-plasty, grafts or local skin flaps to interrupt the vicious circle between scar tension and consecutive further thickening of the scar due to permanently stimulated ECM production.16
  4. Hypertrophic scars and keloids that have developed on the basis of delayed wound healing (eg, after deep dermal burn or wound infection) are transformed by surgery (excision with suture or graft) into a wound with appropriate healing time, thus minimizing the risk of a new excessive scar formation.16
  5. By surgical removal of excessive scar tissue, a situation corresponding to a fresh wound is achieved, in which renewed excessive scarring can be reduced by adjuvant conservative therapy from the very beginning.16 However, excision of keloids without any adjuvant therapy (eg, post-excisional corticosteroid injections, 5-fluorouracil (5-FU), intraoperative cryotherapy, pressure, or radiations) should be strictly avoided due to great recurrence rates (45%–100%). Excisions of the keloid may result in a longer scar than the original one, and recurrence in this new area of trauma may lead to an even larger keloid.17,18 Interestingly, surgical repair (core excision with low-tension wound closure, or shave excision) of earlobe keloids with post-surgery corticosteroid injections, postoperative pressure (pressure earrings), application of imiquimod 5% cream, or cryotherapy on the incision site has been shown to provide overall good cosmetic results.19
Posted in Scars | Leave a comment

Thyroid Medicines

Thyroid medicines for replacement and suppression in the Philippines

Levothyroxine

  • Eltroxin
  • Eurolev
  • Euthyrox
  • Thyrax
  • Thydin

Range: 25 mcg to 200 mcg / day

Take 30 to 60 minutes before breakfast or before dinner

As much as possible, do not use with other drugs

Antithyroid drugs

  • Prophylthiouracil – 50mg/tab
  • Methimazole – Tapazol – 5 mg / tab
  • Carbimazole – Neomercazole – 5 mg / tab
  • Thiamazole – Strumazol – 10 mg / tab

Titrate to control (high to low)

ROJ@15sept11

Posted in Thyroid | Leave a comment

Thyroid – Multiple Colloid Adenomatous Goiter with Focus of Papillary Carcinoma – ROJoson – 14Sept1

mcag_thyroid_ca_josie_14aug  1aMultiple Colloid Adenomatous Goiter

mcag_thyroid_ca_josie_14aug  (1)Opened colloid cyst at upper pole of left lobe and adenomatous goiter in the entire gland.

mcag_thyroid_ca_josie_14aug  (4)

1-cm focus on the right lobe (white, hard nodule). See pictures below with pointers.

mcag_thyroid_ca_josie_14aug  (5)

mcag_thyroid_ca_josie_14aug  (2)

ROJ@14sept1

Posted in Thyroid | Leave a comment

Thyroid Cancer – Papillary Carcinoma with Central and Lateral Node Metastases – ROJoson – 14Sept1

Papillary Thyroid Carcinoma, Right Lobe, with Central and Lateral Node Metastases

Operation done: total thyoidectomy and neck dissection, central and right lateral

Note one of the lateral lower nodes is black in color which is a telltale sign of papillary nodal metastasis.

thyroid_ca_joiz_lu_14aug20 (1)

thyroid_ca_joiz_lu_14aug20 (2)

thyroid_ca_joiz_lu_14aug20 (3)

ROJ@14sept1

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

Patient received RAI therapy postoperatively.

6 months after, there is a recurrence on the right neck, which was excised.

DSC05902

DSC05903

DSC05904

DSC05905ROJ@15mar30

Posted in Thyroid | Leave a comment

Rhomboid Flap in Scalp Defect Reconstruction – ROJoson -14Sept1

Use of rhomboid flap after a wide excision of skin and soft tissue malignancy in the scalp (occipital area)

denis_ocayo_scalp_rhomboid_14sept1 (1)

denis_ocayo_scalp_rhomboid_14sept1 (2)

denis_ocayo_scalp_rhomboid_14sept1 (3)

Preliminary planning and drawing

denis_ocayo_scalp_rhomboid_14sept1 (4)

Recurrent malignancy, left posterior auricular area

denis_ocayo_scalp_rhomboid_14sept1 (5)

Outline of elliptical incision with margin around the tumor – around 1 cm.

denis_ocayo_scalp_rhomboid_14sept1 (6)

Outline of rhomboid flap

denis_ocayo_scalp_rhomboid_14sept1 (7)

Incision adjusted to a rhomboid with planning of rhomboid flap

denis_ocayo_scalp_rhomboid_14sept1 (8)

Some tentative planning for dog ears.

denis_ocayo_scalp_rhomboid_14sept1 (10)

After wide excision of the malignancy – with resultant scalp defect – about 3.5 cm wide (transverse axis).

denis_ocayo_scalp_rhomboid_14sept1 (12)

Creation of the rhomboid flap

denis_ocayo_scalp_rhomboid_14sept1 (13)

Rhomboid flap rotated to the main scalp defect.

denis_ocayo_scalp_rhomboid_14sept1 (13b)

Temporary guide sutures placed.

denis_ocayo_scalp_rhomboid_14sept1 (14)

Wound repaired and closed with internal sutures with a rubber drain.

denis_ocayo_scalp_rhomboid_14sept1 (18)

Wound repair completed with external sutures.

denis_ocayo_scalp_rhomboid_14sept1 (19)

Specimen view from the surface.

denis_ocayo_scalp_rhomboid_14sept1 (20)

Cut section of the specimen showing the two tumors.

ROJ@14sept1

Posted in Head and Neck Reconstruction, Rhomboid Flaps, Scalp Reconstruction, Scalp Tumors | Leave a comment